Pardes Biosciences Inc (PRDS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 100,266 | 47,164 | 59,284 | 209,055 | 228,599 |
| Marketable Securities | 52,931 | 125,067 | 138,056 | N/A | N/A |
| TOTAL | $157,310 | $176,145 | $200,402 | $214,041 | $233,853 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 0 | 0 | 219 | 0 | 0 |
| TOTAL | $N/A | $N/A | $219 | $N/A | $N/A |
| Total Assets | $157,310 | $176,145 | $200,621 | $214,041 | $233,853 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 14 | 3,715 | 4,929 | 1,569 | 1,684 |
| Accrued Expenses | 1,911 | 7,700 | 15,496 | 10,459 | 9,537 |
| TOTAL | $1,925 | $11,415 | $20,425 | $12,028 | $11,221 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,925 | $11,415 | $20,425 | $12,028 | $11,221 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 62,012 | 61,717 | 61,717 | 62,321 | 62,321 |
| Common Shares | 6 | 6 | 6 | 6 | 6 |
| Retained earnings | -176,738 | -165,963 | -148,158 | -123,936 | -100,601 |
| Other shareholders' equity | 9 | -23 | -24 | 0 | 0 |
| TOTAL | $155,385 | $164,730 | $180,196 | $202,013 | $222,632 |
| Total Liabilities And Equity | $157,310 | $176,145 | $200,621 | $214,041 | $233,853 |